Gates Frontier
Funding rounds backed by Gates Frontier.
- Funding disclosed in full
- $630M
- Median round
- $257M
- Rounds in calculation
- 3
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| LifeMine Therapeutics Develops fungal genome-derived therapeutics for organ transplant rejection | $263MSeries D+Series E | BiotechUnited States | |||
| Cellares Develops automated cell therapy manufacturing platforms | $257MSeries D | BiotechUnited States | |||
| Neurophos Develops photonic AI inference chips for data centers | $110MSeries A | AIUnited States |